The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females
NCT07199244 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61
Last updated 2025-09-30
Summary
The goal of this study is to identify how well a fish-based iron supplement is absorbed and to learn how many, if any, digestive related side effects are caused by ingesting the supplement.
Conditions
- Anemia
- Iron Deficiency (Without Anemia)
- Iron Absorption
Interventions
- DIETARY_SUPPLEMENT
-
marine-based heme iron
Participants will consume 9mg of SalmoFer on day 1, followed by 6mg each day for 56 days.
Sponsors & Collaborators
-
Nutraceuticals Research Institute
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 42 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-08-01
- Primary Completion
- 2025-05-31
- Completion
- 2025-10-31
Countries
- United States
Study Locations
More Related Trials
-
A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia
NCT00399191 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy
NCT01588665 ·Status: COMPLETED
-
The Optimization of Bioavailability From Iron Supplements: Study 2
NCT02177851 ·Status: COMPLETED ·Phase: NA
-
IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding
NCT04205266 ·Status: RECRUITING ·Phase: PHASE4
-
Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients
NCT05355766 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study of the Effect of Food on Etavopivat in Healthy Participants
NCT06433661 ·Status: COMPLETED ·Phase: PHASE1
-
Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia
NCT05047211 ·Status: COMPLETED ·Phase: PHASE4
-
Hypoferritinemia Without Anemia Among Reproductive Age Females
NCT06437080 ·Status: COMPLETED ·Phase: NA
-
Inhibitory Effect of a Polyphenol Supplement on Dietary Iron Absorption in Adults with Thalassemia
NCT05326503 ·Status: COMPLETED ·Phase: NA
-
Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
NCT00000588 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Clinical Study of CN128 in Thalassemia Patients
NCT04614779 ·Status: COMPLETED ·Phase: PHASE2
-
Iron Absorption From Plant Heme Iron
NCT07143890 ·Status: RECRUITING ·Phase: NA
-
A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo
NCT02172001 ·Status: WITHDRAWN ·Phase: PHASE3
-
Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
NCT01374919 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects
NCT04778072 ·Status: UNKNOWN ·Phase: NA
-
Different Iron Supplements for Prevention of Anemia in Pregnancy
NCT02487719 ·Status: UNKNOWN ·Phase: PHASE4
-
Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation
NCT01785407 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
Malabsorption as a Cause of Iron Treatment Failure in Infants
NCT00456729 ·Status: COMPLETED ·Phase: NA
-
Alternate Day Versus Daily Oral Iron Therapy in Adolescents
NCT05007899 ·Status: COMPLETED ·Phase: PHASE4
-
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
NCT01506726 ·Status: TERMINATED ·Phase: PHASE2
-
Plasma Hepcidin Response to Differently Dosed Iron Supplements
NCT04735848 ·Status: COMPLETED ·Phase: NA
-
Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement
NCT03990181 ·Status: COMPLETED ·Phase: NA
-
Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women
NCT06851130 ·Status: RECRUITING ·Phase: NA
-
Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
NCT00548860 ·Status: COMPLETED ·Phase: PHASE3